BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12593796)

  • 1. hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl.
    Hall AB; Jura N; DaSilva J; Jang YJ; Gong D; Bar-Sagi D
    Curr Biol; 2003 Feb; 13(4):308-14. PubMed ID: 12593796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for direct interaction between Sprouty and Cbl.
    Wong ES; Lim J; Low BC; Chen Q; Guy GR
    J Biol Chem; 2001 Feb; 276(8):5866-75. PubMed ID: 11053437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function.
    Fong CW; Leong HF; Wong ES; Lim J; Yusoff P; Guy GR
    J Biol Chem; 2003 Aug; 278(35):33456-64. PubMed ID: 12815057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops.
    Rubin C; Litvak V; Medvedovsky H; Zwang Y; Lev S; Yarden Y
    Curr Biol; 2003 Feb; 13(4):297-307. PubMed ID: 12593795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling.
    Wong ES; Fong CW; Lim J; Yusoff P; Low BC; Langdon WY; Guy GR
    EMBO J; 2002 Sep; 21(18):4796-808. PubMed ID: 12234920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
    Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
    J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of sprouty stability by Mnk1-dependent phosphorylation.
    DaSilva J; Xu L; Kim HJ; Miller WT; Bar-Sagi D
    Mol Cell Biol; 2006 Mar; 26(5):1898-907. PubMed ID: 16479008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7.
    Yokouchi M; Kondo T; Houghton A; Bartkiewicz M; Horne WC; Zhang H; Yoshimura A; Baron R
    J Biol Chem; 1999 Oct; 274(44):31707-12. PubMed ID: 10531381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins.
    Egan JE; Hall AB; Yatsula BA; Bar-Sagi D
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6041-6. PubMed ID: 11983899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
    Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
    J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors.
    Ettenberg SA; Rubinstein YR; Banerjee P; Nau MM; Keane MM; Lipkowitz S
    Mol Cell Biol Res Commun; 1999 Aug; 2(2):111-8. PubMed ID: 10542134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation.
    Magnifico A; Ettenberg S; Yang C; Mariano J; Tiwari S; Fang S; Lipkowitz S; Weissman AM
    J Biol Chem; 2003 Oct; 278(44):43169-77. PubMed ID: 12907674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
    Goh EL; Zhu T; Leong WY; Lobie PE
    Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation.
    Howlett CJ; Robbins SM
    Oncogene; 2002 Mar; 21(11):1707-16. PubMed ID: 11896602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinases.
    Sanjay A; Horne WC; Baron R
    Sci STKE; 2001 Nov; 2001(110):pe40. PubMed ID: 11724969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
    Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
    J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulator of epidermal growth factor signaling: Sprouty.
    Wong ES; Guy GR
    Methods Mol Biol; 2006; 327():61-83. PubMed ID: 16780213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel role of Sprouty 2 in regulating cellular apoptosis.
    Edwin F; Patel TB
    J Biol Chem; 2008 Feb; 283(6):3181-3190. PubMed ID: 18070883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitinylation and proteasome-dependent degradation of the phosphoinositide-specific phospholipase C gamma 1 in A-431 cells.
    Evdonin AL; Tsupkina NV; Nikol'skii NN; Medvedeva ND
    Dokl Biol Sci; 2003; 392():456-7. PubMed ID: 14650885
    [No Abstract]   [Full Text] [Related]  

  • 20. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination.
    Alwan HA; van Zoelen EJ; van Leeuwen JE
    J Biol Chem; 2003 Sep; 278(37):35781-90. PubMed ID: 12829707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.